Axsome Q3 Auvelity New Prescriptions In Patients 65+ Up 211% Y/Y On Alzheimer's Agitation Use
Share
Why It Matters
Axsome's Auvelity medicine is being prescribed much more to older adults with Alzheimer's. When a new medicine gets prescribed a lot in a growing patient group, it shows real doctor confidence and demand.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.